Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia
Kantarjian, Hagop M., Su, Yun, Jabbour, Elias J., Bhattacharyya, Helen, Yan, Eric, Cappelleri, Joseph C., Marks, David I.
Published in Cancer (15.05.2018)
Published in Cancer (15.05.2018)
Get full text
Journal Article
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus
Itani, Kamal M.F., M.D., F.A.C.S, Dryden, Matthew S., M.D., F.R.C.P, Bhattacharyya, Helen, Ph.D, Kunkel, Mark J., M.D, Baruch, Alice M., M.D., Ph.D, Weigelt, John A., M.D., D.V.M., F.A.C.S
Published in The American journal of surgery (01.06.2010)
Published in The American journal of surgery (01.06.2010)
Get full text
Journal Article
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus
Wunderink, Richard G, Mendelson, Meryl H, Somero, Michael S, Fabian, Timothy C, May, Addison K, Bhattacharyya, Helen, Leeper, Jr, Kenneth V, Solomkin, Joseph S
Published in Chest (01.12.2008)
Published in Chest (01.12.2008)
Get more information
Journal Article
Clinical Efficacy of Oral Linezolid Compared With Intravenous Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus –Complicated Skin and Soft Tissue Infections: A Retrospective, Propensity Score–Matched, Case-Control Analysis
Itani, Kamal M.F., MD, Biswas, Pinaki, PhD, Reisman, Arlene, MPH, Bhattacharyya, Helen, PhD, Baruch, Alice M., MD, PhD
Published in Clinical therapeutics (01.08.2012)
Published in Clinical therapeutics (01.08.2012)
Get full text
Journal Article
Azithromycin Combination Therapy with Artesunate or Quinine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Adults: A Randomized, Phase 2 Clinical Trial in Thailand
Noedl, Harald, Krudsood, Srivicha, Chalermratana, Kobsiri, Silachamroon, Udomsak, Leowattana, Wattana, Tangpukdee, Noppadon, Looareesuwan, Sornchai, Miller, Robert Scott, Fukuda, Mark, Jongsakul, Krisada, Sriwichai, Sabaithip, Rowan, Jacqueline, Bhattacharyya, Helen, Ohrt, Colin, Knirsch, Charles
Published in Clinical infectious diseases (15.11.2006)
Published in Clinical infectious diseases (15.11.2006)
Get full text
Journal Article
Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis
Marple, Bradley F., MD, Roberts, Craig S., PharmD, Frytak, Jennifer R., PhD, Schabert, Vernon F., PhD, Wegner, Jessica C, Bhattacharyya, Helen, PhD, Piccirillo, Jay F., MD, Sanchez, Sonia P., MD
Published in American journal of otolaryngology (2010)
Published in American journal of otolaryngology (2010)
Get full text
Journal Article
Abstract PD10-01: Patient-reported outcomes in patients with HER2- advanced breast cancer and a germline BRCA1/2 mutation receiving talazoparib vs physician’s choice of chemotherapy: A focus on EMBRACA ECOG performance status subgroups
Rugo, Hope S, Quek, Ruben G. W., Bhattacharyya, Helen, Gonçalves, Anthony, Ettl, Johannes, Hurvitz, Sara A.
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Health-related quality of life (HRQoL) in patients with untreated higher-risk myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML) receiving glasdegib + azacitidine (AZA)
Wang, Eunice S., Bell, Timothy, Zeidan, Amer Methqal, Bhattacharyya, Helen, Kudla, Art, Chan, Geoffrey, Sekeres, Mikkael A.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Quality-Adjusted Survival for Low-Dose Cytarabine (LDAC) Versus Glasdegib+LDAC Among Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Not Candidates for Intensive Chemotherapy: A Q-TWiST Analysis
Kwon, Youngmin, Bell, Timothy J, Solem, Caitlyn, Cappelleri, Joseph C, Johnson, Courtney, Bhattacharyya, Helen, Hoang, Caroline J., Cortes, Jorge E.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
García-Sáenz, José Angel, Marmé, Frederik, Untch, Michael, Bonnefoi, Hervé, Kim, Sung-Bae, Bear, Harry, Mc Carthy, Nicole, Gelmon, Karen, Martin, Miguel, Kelly, Catherine M., Reimer, Toralf, Toi, Masakazu, Law, Ernest, Bhattacharyya, Helen, Gnant, Michael, Makris, Andreas, Seiler, Sabine, Burchardi, Nicole, Nekljudova, Valentina, Loibl, Sibylle, Rugo, Hope S.
Published in European journal of cancer (1990) (01.01.2024)
Published in European journal of cancer (1990) (01.01.2024)
Get full text
Journal Article
Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1
Saad, Fred, de Bono, Johann, Barthélémy, Philippe, Dorff, Tanya, Mehra, Niven, Scagliotti, Giorgio, Stirling, Adam, Machiels, Jean-Pascal, Renard, Vincent, Maruzzo, Marco, Higano, Celestia S., Gurney, Howard, Healy, Cynthia, Bhattacharyya, Helen, Arondekar, Bhakti, Niyazov, Alexander, Fizazi, Karim
Published in European urology (01.04.2023)
Published in European urology (01.04.2023)
Get full text
Journal Article
A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy
Solem, Caitlyn T., Bell, Timothy J., Kwon, Youngmin, Cappelleri, Joseph C., Johnson, Courtney, Bhattacharyya, Helen, Hoang, Caroline J., Cortes, Jorge E.
Published in Cancer (01.10.2020)
Published in Cancer (01.10.2020)
Get full text
Journal Article
Impact of Disease Progression Status on time to Deterioration of Patient Reported Health Related Quality of Life in Forst Line ER+ HER2-VE Advanced/Metastatic Breast Cancer Patients in the PALOMA-2 Study
Harbeck, Nadia, Iyer, Shrividya, Bhattacharyya, Helen, Mori, Ave, Ettl, Johannes
Published in Breast (Edinburgh) (01.11.2017)
Published in Breast (Edinburgh) (01.11.2017)
Get full text
Journal Article
OR65 - Impact of Disease Progression Status on time to Deterioration of Patient Reported Health Related Quality of Life in Forst Line ER+ HER2-VE Advanced/Metastatic Breast Cancer Patients in the PALOMA-2 Study
Harbeck, Nadia, Iyer, Shrividya, Bhattacharyya, Helen, Mori, Ave, Ettl, Johannes
Published in Breast (Edinburgh) (01.11.2017)
Published in Breast (Edinburgh) (01.11.2017)
Get full text
Journal Article
PO130 - PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS (PTS) WITH HER2− ADVANCED BREAST CANCER (ABC) RECEIVING TALAZOPARIB (TALA) VS PHYSICIAN’S CHOICE CHEMOTHERAPY (PCT): A FOCUS ON EMBRACA GERMLINE BRCA1 AND BRCA2 MUTATION (GBRCA1/2M) SUBGROUPS
Gonçalves, Anthony, Quek, Ruben G.W., Bhattacharyya, Helen, Ettl, Johannes, Hurvitz, Sara A., Rugo, Hope S.
Published in Breast (Edinburgh) (01.11.2019)
Published in Breast (Edinburgh) (01.11.2019)
Get full text
Journal Article
PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS (PTS) WITH HER2− ADVANCED BREAST CANCER (ABC) RECEIVING TALAZOPARIB (TALA) VS PHYSICIAN’S CHOICE CHEMOTHERAPY (PCT): A FOCUS ON EMBRACA GERMLINE BRCA1 AND BRCA2 MUTATION (GBRCA1/2M) SUBGROUPS
Gonçalves, Anthony, Quek, Ruben G.W., Bhattacharyya, Helen, Ettl, Johannes, Hurvitz, Sara A., Rugo, Hope S.
Published in Breast (Edinburgh) (01.11.2019)
Published in Breast (Edinburgh) (01.11.2019)
Get full text
Journal Article
Patient-reported outcomes (PRO) from a global phase 3 randomized controlled trial (RCT) of inotuzumab ozogamicin (InO) vs standard care (SC) for relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL)
Kantarjian, Hagop M, Su, Yun, Bhattacharyya, Helen, Yan, Eric, Shapiro, Mark, Cappelleri, Joseph C
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Patient-Reported Outcomes from a Global Phase 3 Randomized Controlled Trial of Inotuzumab Ozogamicin Versus Standard of Care Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
Kantarjian, Hagop M., Su, Yun, Jabbour, Elias J., Bhattacharyya, Helen, Yan, Eric, Shapiro, Mark, Cappelleri, Joseph C., Marks, David I.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Patient-reported outcomes (PROs) in patients (pts) with advanced breast cancer (aBC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician’s choice chemotherapy treatment (PCT): a focus on the EMBRACA HR+/HER2- subpopulation
Hurvitz, Sara A., Quek, Ruben G.W., Ettl, Johannes, Rugo, Hope, Bhattacharyya, Helen, Hannah, Alison L., Litton, Jennifer Keating
Published in Breast (Edinburgh) (01.10.2018)
Published in Breast (Edinburgh) (01.10.2018)
Get full text
Journal Article
Sunitinib and pazopanib treatment patterns and cost outcomes in Medicare supplemental-covered patients with renal cell carcinoma
Harnett, James, MacLean, Elizabeth A., Bhattacharyya, Helen, Cisar, Laura A., Hoang, Caroline, Mardekian, Jack
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article